SynthesisRevista clinica espanola2022

Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.

D Patoulias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.